Epsilon M&A Deal Report - OctoPlus
Transaction Multiples for the Valuation of Private Companies
Dr Reddys Laboratories / OctoPlus
No EMAT :
52525
Announced Date :
22/10/2012
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Dr Reddys Laboratories
Target :
OctoPlus
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Founded in 1995, OctoPlus operates as a specialty pharmaceutical company focused on the development and manufacture of improved injectable pharmaceuticals based on proprietary drug delivery...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns | ns |
|
|||
| Current |
|
ns | ns | ns | ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/10/2012 | Amil Participacoes | HPP - Hospitais Privados De Portugal SGPS | Portugal | ** | 52495 |
| 06/11/2012 | ExonHit | InGen BioSciences | France | *** | 52397 |
Source: Epsilon Research / EMAT
